Showing results (291-300 of 319) with videos related to
Sort By:
Pageof 32
Alimentary Pharmacology & Therapeutics|January 14, 2026
Tumour Burden Score as a Predictor of Extrahepatic Progression After Transarterial Chemoembolization for Hepatocellular Carcinoma: An Observational Multicenter StudyElisa Pinto, Filippo Pelizzaro, Vittorio Simeon, et al.Oncology Research|April 3, 2026
The Effect of Metformin on Atezolizumab/Bevacizumab Treatment in Patients with Hepatocellular Carcinoma and DiabetesAndrea Dalbeni, Marco Vicardi, Leonardo A Natola, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 12, 2022
Validation of the easy-to-use lenvatinib prognostic index to predict prognosis in advanced hepatocellular carcinoma patients treated with lenvatinibMargherita Rimini, Wonseok Kang, Valentina Burgio, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 4, 2026
Unmet needs in hepatology: The guidance of the Italian association for the study of the liver (AISF)Stefano Gitto, Filippo Gabrielli, Giovanni Addolorato, et al.Cancers|June 2, 2021
A Nomogram-Based Prognostic Model for Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib: A Multicenter StudyGiovanni Marasco, Francesco Poggioli, Antonio Colecchia, et al.Cancers|March 6, 2021
Surveillance as Determinant of Long-Term Survival in Non-Transplanted Hepatocellular Carcinoma PatientsFilippo Pelizzaro, Alessandro Vitale, Anna Sartori, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 27, 2025
The "A-B-C" Classification Reveals Outcome Trajectories in Patients With Hepatocellular Carcinoma Under Atezolizumab/BevacizumabClaudia Campani, Clelia Galvanin, Ju Hyun Shim, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 30, 2018
Under-dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non-randomized Study of Patients With CirrhosisFilippo Schepis, Francesco Vizzutti, Guadalupe Garcia-Tsao, et al.Cancer Management and Research|January 7, 2022
Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in ItalyValentina Burgio, Massimo Iavarone, Giovanni Giuseppe Di Costanzo, et al.Journal of Hepatology|June 23, 2025
Impact of first and further decompensation in patients with compensated ACLD due to MASLDGrazia Pennisi, Gabriele Di Maria, Vincent Wai-Sun Wong, et al.Pageof 32